Maxirnus, go back to the Dec. 4 posting by lokodaug. II is the most
comprehensible status of where Teva is with Copaxone today.
Read carefully and learn something.
Maxirnus, carefully read post be lokodaug. If you have enough
comprehension to digest all the facts, you'll be a more well
Sorry to break your bubble. There is no generic Copaxone approved by FDA. Mylans been
trying for two years. Also, no generic for Europe or Netherlands.
And you greedy comment has been shot down so many times, you using it assumes
your are mentally devoid of digesting informative posts. LOL.
And let me know who is going to make generic Copaxone. It's
not happening in Europe and Netherlands, so why would it happen here.
Logic 101 again.
Sorry to have to remind you for the tenth time, Teva BOD's average
over 50,000 less in compensation than similar companies. But don,t
let facts get in you way; keep on posting your repitive drivel.
We're now up 10% since 11-1. t
This bag is doing pretty good. And
my Dec. 40 call options are now up 60%. Good luck standing on
the sidelines watching. Loser.
Mylan is 16.5 billion market cap co. Don't think they will be any factor in what
is now going on. With volume and price up, I would think some news would
be breaking soon.
You're missing the big picture. What you now see are
investors going in on what is one of the most undervalued
Teva up 8 % since 11-1. It's just getting going.